Oral Dosages of the NSAID Aspirin Decreased the Growth Rate of Species Found in the Human Gut Microbiome Including Akkermansia muciniphila, Bacteroides fragilis, Clostridium sordellii, and Clostridium difficile

Over past few decades, new insight has been revealed in the scientific community about the importance of the human gut microbiome relating to general health. It is known that imbalances in the species that reside in the human gut can cause organism-wide problems in humans. When prescribing or injecting oral medications, the thought of the downstream effects on the gut microbiome are not always considered. By exposing known healthy members of the gut; Akkermansia muciniphila, Bacteroides fragilis, Clostridium sordellii, and Clostridium difficile to the Aspirin, this study attempted to provide insight into the effects of the drug on bacterial growth. While these species only account for a small percentage of the total biodiversity of the gut microbiome, they are some of the most thoroughly studied and well known. A. muciniphila is known to occur in higher concentrations in healthy, low body mass index individuals which suggests that aspirin alternatives may be beneficial in some clinical cases. To accomplish the goal of this study, time courses were designed to analyze if different dosages of Aspirin inhibited the growth curve of each species when compared to growth curves of the same species in drug-free media. Aspirin was found to have a dose-dependent effect in growth rate of A. muciniphila, B. fragilis, C. sordellii, and C. difficile resulting in a significant decrease in the exponential growth phase of all four species. This suggested that aspirin inhibited cell culture growth in a dose-dependent manner. Aspirin’s toxic affect to these important commensal species of the human gut should be considered by practitioners prior to prescription

Mixed-Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of β-Cell Function in Therapeutic Trials in Type 1 Diabetes

OBJECTIVE—β-Cell function in type 1 diabetes clinical trials is commonly measured by C-peptide response to a secretagogue in either a mixed-meal tolerance test (MMTT) or a glucagon stimulation test (GST). The Type 1 Diabetes TrialNet Research Group and the European C-peptide Trial (ECPT) Study Group conducted parallel randomized studies to compare the sensitivity, reproducibility, and tolerability of these procedures

Parameter scaling in the decoherent quantum-classical transition for chaotic systems

The quantum to classical transition has been shown to depend on a number of parameters. Key among these are a scale length for the action, $\hbar$, a measure of the coupling between a system and its environment, $D$, and, for chaotic systems, the classical Lyapunov exponent, $\lambda$. We propose computing a measure, reflecting the proximity of quantum and classical evolutions, as a multivariate function of $(\hbar,\lambda,D)$ and searching for transformations that collapse this hyper-surface into a function of a composite parameter $\zeta = \hbar^{\alpha}\lambda^{\beta}D^{\gamma}$. We report results for the quantum Cat Map, showing extremely accurate scaling behavior over a wide range of parameters and suggest that, in general, the technique may be effective in constructing universality classes in this transition.Comment: Submitte

Hepatitis B surface antigen in urine of hemodialysis patients

Hepatitis B surface antigen in urine of hemodialysis patients. As part of an extensive epidemiological survey of chronic hemodialysis patients in Michigan, hepatitis B surface antigen (HBsAg) was identified in the sera of 79 of 701 (11%) patients. Of these patients, 59 were carriers of HBsAg for three or more months. Urine samples were collected from 36 of 39 HBsAg carriers having urinary output. Of these samples, 19 (52%) were positive for HBsAg by radioimmunoassay; this was confirmed by specific antibody neutralization. The HBsAg was not identified in the urine of seven hemodialysis patients who were lacking serum HBsAg or in urine samples from three HBsAg sero-carriers who had normal renal function. Patients undergoing maintenance hemodialysis appear to constitute a large reservoir of HBsAg chronic carriers. This study indicates that a minimum of 50% of persistent HBsAg carriers who are producing urine have detectable. HBsAg in single, randomly timed, unconcentrated urine specimen. These data suggest that urine may represent a potential vehicle for transmission in nonparenterally acquired hepatitis B.Antigène de surface de l'hépatite B dans l'urine de malades en hémodialyse. Dans le cadre d'une large enquête épidémiologique à propos des malades en hémodialyse chronique dans le Michigan, l'antigène de surface de l'hépatite B (HBsAg) a été identifié dans le sérum de 79 parmi 701 malades (11%). Parmi ces malades, 59 étaient des porteurs de HBsAg depuis 3 mois ou plus. L'urine de 36 des 39 porteurs de HBsAg, qui avaient une diurèse, a été recueillie. Parmi ces 36 urines, 19 (52%) sont positives pour HBsAg par radio-immunologie, ce qui est confirmé par la neutralisation au moyen d'anticorps spécifique. Le HBsAg n'apas été identifié dans l'urine de 7 malades en hémodialyse qui n'avaient pas le HBsAg sérique et dans l'urine de 3 porteurs de HBsAg dont les fonctions rénales étaient normales. Les malades soumis à l'hémodialyse itérative paraissent constituer un grand réservoir de porteurs chroniques de HBsAg. Cette étude indique qu'au minimum 50% des porteurs chroniques de HBsAg qui ont une diurèse, ont un HBsAg détectable dans un échantillon unique d'urine, prélevé au hasard, non concentré. Ces résultats suggèrent que l'urine peut être un véhicule de transmission de l'hépatite B acquise par voie non parentérale

Suspension and Measurement of Graphene and Bi2Se3 Atomic Membranes

Coupling high quality, suspended atomic membranes to specialized electrodes enables investigation of many novel phenomena, such as spin or Cooper pair transport in these two dimensional systems. However, many electrode materials are not stable in acids that are used to dissolve underlying substrates. Here we present a versatile and powerful multi-level lithographical technique to suspend atomic membranes, which can be applied to the vast majority of substrate, membrane and electrode materials. Using this technique, we fabricated suspended graphene devices with Al electrodes and mobility of 5500 cm^2/Vs. We also demonstrate, for the first time, fabrication and measurement of a free-standing thin Bi2Se3 membrane, which has low contact resistance to electrodes and a mobility of >~500 cm^2/Vs

Biobanking, consent, and commercialization in international genetics research: the Type 1 Diabetes Genetics Consortium

Background and Purpose This article describes several ethical, legal, and social issues typical of international genetics biobanking, as encountered in the Type 1 Diabetes Genetics Consortium (T1DGC)

Bone CLARITY: Clearing, imaging, and computational analysis of osteoprogenitors within intact bone marrow

Bone tissue harbors unique and essential physiological processes, such as hematopoiesis, bone growth, and bone remodeling. To enable visualization of these processes at the cellular level in an intact environment, we developed “Bone CLARITY,” a bone tissue clearing method. We used Bone CLARITY and a custom-built light-sheet fluorescence microscope to detect the endogenous fluorescence of Sox9-tdTomato+ osteoprogenitor cells in the tibia, femur, and vertebral column of adult transgenic mice. To obtain a complete distribution map of these osteoprogenitor cells, we developed a computational pipeline that semiautomatically detects individual Sox9-tdTomato+ cells in their native three-dimensional environment. Our computational method counted all labeled osteoprogenitor cells without relying on sampling techniques and displayed increased precision when compared with traditional stereology techniques for estimating the total number of these rare cells. We demonstrate the value of the clearing-imaging pipeline by quantifying changes in the population of Sox9-tdTomato–labeled osteoprogenitor cells after sclerostin antibody treatment. Bone tissue clearing is able to provide fast and comprehensive visualization of biological processes in intact bone tissue

Pulling together: keeping track of pedagogy, design and evaluation through the development of scenarios: a case study

This case study describes the multipurpose use of scenarios in a large multinational research project (MOBIlearn) whose aims are to design and develop a pedagogically sound mobile learning environment. Maintaining effective communication and design focus in large consortia is a wellknown problem (see Carroll, 2000), and we describe the role of scenarios in addressing this. Scenarios were initially used to simply envision the future system in order to inform design, but as the project progressed, the role of the scenarios grew to encompass (i) relating system design and implementation to pedagogy by providing a common frame of reference for developers and pedagogic experts; (ii) through a process of refinement, defining the evaluation strategy for the user trials; and (iii) allowing us to keep the user at the heart of the development project. Thus, scenarios helped to resolve the difficulty identified by Taylor (2004) of how to bring together the relatively high level issues of pedagogic evaluation and the more technical user-centred system evaluation. The development of a first-aid training scenario is used as an illustrative example